Want to create an interactive transcript for this episode?
Podcast: OncLive® On Air
Episode: Tumor Board: Translating HER2 and TROP2 Innovations to Transform NSCLC Care
Description: In this podcast, experts Jacob Sands, MD; Marina Chiara Garassino, MD; and Eric Singhi, MD; use realistic cases to explore key decision points in applying HER2- and TROP2-targeted therapies across the non–small cell lung cancer (NSCLC) continuum, including patient selection, sequencing, and toxicity management.